These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16252375)

  • 21. All-cause mortality associated with atypical and conventional antipsychotics among nursing home residents with dementia: a retrospective cohort study.
    Liperoti R; Onder G; Landi F; Lapane KL; Mor V; Bernabei R; Gambassi G
    J Clin Psychiatry; 2009 Oct; 70(10):1340-7. PubMed ID: 19906339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risperidone use in Korean patients with Alzheimer's disease: optimal dosage and effect on behavioural and psychological symptoms, cognitive function and activities of daily living.
    Yoon JS; Kim JM; Lee H; Shin IS; Choi SK
    Hum Psychopharmacol; 2003 Dec; 18(8):627-33. PubMed ID: 14696022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.
    Citrome L; Jaffe A; Levine J
    Schizophr Res; 2010 Jun; 119(1-3):153-9. PubMed ID: 20347267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of atypical antipsychotics in nursing homes.
    Liperoti R; Mor V; Lapane KL; Pedone C; Gambassi G; Bernabei R
    J Clin Psychiatry; 2003 Sep; 64(9):1106-12. PubMed ID: 14628988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behavioral and psychological symptoms in patients with dementia as a target for pharmacotherapy with risperidone.
    Rabinowitz J; Katz IR; De Deyn PP; Brodaty H; Greenspan A; Davidson M
    J Clin Psychiatry; 2004 Oct; 65(10):1329-34. PubMed ID: 15491235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of behavioral disorders in dementia with risperidone in psychogeriatric out-patients].
    Kurz A; Delius-Stute H; Rettig K; Schwalen S
    MMW Fortschr Med; 2003 Oct; 145 Suppl 3():89-95. PubMed ID: 15490773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's disease.
    Lopez OL; Becker JT; Chang YF; Sweet RA; Aizenstein H; Snitz B; Saxton J; McDade E; Kamboh MI; DeKosky ST; Reynolds CF; Klunk WE
    Am J Psychiatry; 2013 Sep; 170(9):1051-8. PubMed ID: 23896958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics.
    Finkel S; Kozma C; Long S; Greenspan A; Mahmoud R; Baser O; Engelhart L
    Int Psychogeriatr; 2005 Dec; 17(4):617-29. PubMed ID: 16202186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mortality in elderly dementia patients treated with risperidone.
    Haupt M; Cruz-Jentoft A; Jeste D
    J Clin Psychopharmacol; 2006 Dec; 26(6):566-70. PubMed ID: 17110812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavioral and Psychological Signs and Symptoms of Dementia (BPSD) in antipsychotic-naïve Alzheimer's Disease patients.
    Suh GH; Kim SK
    Int Psychogeriatr; 2004 Sep; 16(3):337-50. PubMed ID: 15559757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study.
    Huybrechts KF; Gerhard T; Crystal S; Olfson M; Avorn J; Levin R; Lucas JA; Schneeweiss S
    BMJ; 2012 Feb; 344():e977. PubMed ID: 22362541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The course of behavioral problems in elderly nursing home patients with dementia when treated with antipsychotics.
    Kleijer BC; van Marum RJ; Egberts AC; Jansen PA; Frijters D; Heerdink ER; Ribbe M
    Int Psychogeriatr; 2009 Oct; 21(5):931-40. PubMed ID: 19538831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antipsychotics for delirium.
    Lonergan E; Britton AM; Luxenberg J; Wyller T
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005594. PubMed ID: 17443602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Impact of Antipsychotic Drugs on Long-term Care, Nursing Home Admission, and Death in Dementia Patients.
    Nerius M; Johnell K; Garcia-Ptacek S; Eriksdotter M; Haenisch B; Doblhammer G
    J Gerontol A Biol Sci Med Sci; 2018 Sep; 73(10):1396-1402. PubMed ID: 29228107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of Mortality Among Patients Treated With Antipsychotic Medications: A Nationwide Population-Based Study in Taiwan.
    Wang LJ; Lee SY; Yuan SS; Yang KC; Yang CJ; Lee TL; Shyu YC
    J Clin Psychopharmacol; 2016 Feb; 36(1):9-17. PubMed ID: 26658260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short- and long-term mortality risk associated with the use of antipsychotics among 26,940 dementia outpatients: a population-based study.
    Langballe EM; Engdahl B; Nordeng H; Ballard C; Aarsland D; Selbæk G
    Am J Geriatr Psychiatry; 2014 Apr; 22(4):321-31. PubMed ID: 24016844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioral and psychological symptoms of dementia (BPSD) in elderly demented subjects: is the long lasting use of atypical antipsychotic drugs useful and safe?
    Angelini A; Bendini C; Neviani F; Neri M
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():35-43. PubMed ID: 17317431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antipsychotic treatment discontinuation in previously untreated patients with schizophrenia: 36-month results from the SOHO study.
    Haro JM; Novick D; Suarez D; Roca M
    J Psychiatr Res; 2009 Jan; 43(3):265-73. PubMed ID: 18644606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.